These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32783264)

  • 41. A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
    Dutz JP; Lui H
    Int J Dermatol; 1998 Jan; 37(1):51-3. PubMed ID: 9522242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Betamethasone valerate in foam vehicle is effective with both daily and twice a day dosing: a single-blind, open-label study in the treatment of scalp psoriasis.
    Feldman SR; Ravis SM; Fleischer AB; McMichael A; Jones E; Kaplan R; Shavin J; Weiss J; Bartruff JK; Levin DL; Del Rosso J; Kpea N
    J Cutan Med Surg; 2001; 5(5):386-9. PubMed ID: 11907847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life.
    Katugampola RP; Hongbo Y; Finlay AY
    Br J Dermatol; 2005 Jun; 152(6):1256-62. PubMed ID: 15948990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis.
    Feldman SR; Thaçi D; Gooderham M; Augustin M; de la Cruz C; Mallbris L; Buonanno M; Tatulych S; Kaur M; Lan S; Valdez H; Mamolo C
    J Am Acad Dermatol; 2016 Dec; 75(6):1162-1170.e3. PubMed ID: 27692733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcipotriol versus coal tar: a prospective randomized study in stable plaque psoriasis.
    Sharma V; Kaur I; Kumar B
    Int J Dermatol; 2003 Oct; 42(10):834-8. PubMed ID: 14521705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant role of a new emollient cream in patients with palmar and/or plantar psoriasis: a pilot randomized open-label study.
    Cassano N; Mantegazza R; Battaglini S; Apruzzi D; Loconsole F; Vena GA
    G Ital Dermatol Venereol; 2010 Dec; 145(6):789-92. PubMed ID: 21139557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of topical hydrating and emollient lotion containing 10% urea ISDIN® plus dexpanthenol (Ureadin Rx 10) in the treatment of skin xerosis and pruritus in hemodialyzed patients: an open prospective pilot trial.
    Castello M; Milani M
    G Ital Dermatol Venereol; 2011 Oct; 146(5):321-5. PubMed ID: 21956268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Enhanced Lotion Formulation of Halobetasol Propionate, 0.05% Versus Its Vehicle in Adult Subjects With Plaque Psoriasis.
    Pariser D; Bukhalo M; Guenthner S; Kempers S; Shideler S; Gold LS; Tschen E; Berg J; Ferdon MB; Dromgoole S
    J Drugs Dermatol; 2017 Mar; 16(3):234-240. PubMed ID: 28301619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis.
    Green L; Sadoff W
    J Cutan Med Surg; 2002; 6(2):95-102. PubMed ID: 11992180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Salicylic Acid 6% in an ammonium lactate emollient foam vehicle in the treatment of mild-to-moderate scalp psoriasis.
    Kircik L
    J Drugs Dermatol; 2011 Mar; 10(3):270-3. PubMed ID: 21369643
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination.
    Stein Gold L; Kircik LH; Pariser D; Sugarman JL; Lin T; Kang R; Pillai R
    J Drugs Dermatol; 2018 Aug; 17(8):863-868. PubMed ID: 30124725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study).
    Eberlein B; Eicke C; Reinhardt HW; Ring J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):73-82. PubMed ID: 18181976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Observer-blind, randomized, intrapatient comparison of a novel 1% coal tar preparation (Exorex) and calcipotriol cream in the treatment of plaque type psoriasis.
    Tzaneva S; Hönigsmann H; Tanew A
    Br J Dermatol; 2003 Aug; 149(2):350-3. PubMed ID: 12932242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trial.
    Menter A
    Cutis; 2007 Nov; 80(5 Suppl):12-9. PubMed ID: 18154219
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter Study.
    Vendrely V; Mayor-Ibarguren A; Stennevin A; Ortiz-Brugués A
    Dermatol Ther (Heidelb); 2022 Mar; 12(3):683-699. PubMed ID: 35107817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical becocalcidiol for the treatment of psoriasis vulgaris: a randomized, placebo-controlled, double-blind, multicentre study.
    Helfrich YR; Kang S; Hamilton TA; Voorhees JJ
    Br J Dermatol; 2007 Aug; 157(2):369-74. PubMed ID: 17596167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of clinical effects of psoriasis treatment regimens among calcipotriol alone, narrowband ultraviolet B phototherapy alone, combination of calcipotriol and narrowband ultraviolet B phototherapy once a week, and combination of calcipotriol and narrowband ultraviolet B phototherapy more than twice a week.
    Takahashi H; Tsuji H; Ishida-Yamamoto A; Iizuka H
    J Dermatol; 2013 Jun; 40(6):424-7. PubMed ID: 23414298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of a New Emollient-Based Treatment on Skin Microflora Balance and Barrier Function in Children with Mild Atopic Dermatitis.
    Bianchi P; Theunis J; Casas C; Villeneuve C; Patrizi A; Phulpin C; Bacquey A; Redoulès D; Mengeaud V; Schmitt AM
    Pediatr Dermatol; 2016; 33(2):165-71. PubMed ID: 27001317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy.
    Pariser DM; Green LJ; Stein Gold L; Sugarman JL; Lin T; Pillai R
    J Drugs Dermatol; 2018 Jul; 17(7):723-726. PubMed ID: 30005093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
    Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J
    J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.